WORLD Zambia to start administering China's COVID-19 Sinopharm vaccine


Zambia to start administering China's COVID-19 Sinopharm vaccine


22:11, August 25, 2021

LUSAKA, Aug. 25 (Xinhua) -- Zambia will soon start rolling out the Sinopharm COVID-19 vaccine received from China early this month, a government official said on Wednesday.

A batch of China's Sinopharm vaccines arrive at the Kenneth Kaunda International Airport in Lusaka, Zambia, on Aug. 7, 2021. (Photo: Xinhua)

Kennedy Malama, Permanent Secretary in the Ministry of Health in charge of Technical Services said the vaccine will be rolled out in specific districts this week to supplement the other vaccines being administered.

"We are happy to report that we remain commodity secure as far as vaccines are concerned and will continue to acquire additional doses. Vaccination against COVID-19 remains a high impact intervention as it protects one from hospitalization, severe disease and death," he said in a statement on the COVID-19 situation.

He urged members of the public to get vaccinated as the country anticipates the fourth wave of the pandemic at the end of this year and early next year.

The country has been administering the AstraZeneca and Johnson and Johnson vaccine since the launch of the program on April 14, 2021 out of the five approved vaccines for the country.

The official said so far about 558,307 doses out of the 977,600 received have been utilized.

Meanwhile, the official said the government will soon issue guidelines with regards to various restrictions imposed to curtail the spread of the pandemic following reductions in new cases, hospitalizations and deaths.

The country's cumulative cases currently stand at 205,107 following 130 new cases reported in the last 24 hours.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue